Scribe Therapeutics, Inc. (SCTX)
28.05
-4.95
(-15.00%)
USD |
NASDAQ |
Sep 21, 16:00
28.61
+0.56
(+2.00%)
After-Hours: 20:00
Scribe Therapeutics Net Income (Quarterly) : -6.477M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.477M |
| March 31, 2026 | -17.35M |
| Date | Value |
|---|---|
| June 30, 2025 | -9.903M |
| March 31, 2025 | -3.425M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -114.65M |
| Cypherpunk Technologies, Inc. | 39.39M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.918M |
| Total Expenses (Quarterly) | 8.395M |
| EPS Diluted (Quarterly) | -0.3421 |
| Enterprise Value | 745.36M |
| Gross Profit Margin (Quarterly) | 59.07% |
| Profit Margin (Quarterly) | -337.7% |
| Earnings Yield | -7.30% |
| Normalized Earnings Yield | -7.330 |